Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase

Since marketing authorization, cases of neuralgic amyotrophy (NA), facial paralysis/Bell’s palsy (FP/BP), and Guillain-Barré syndrome (GBS) were reported with COVID-19 vaccines of different technologies. This study aimed to assess whether NA, FP/BP, and GBS were more frequently reported in VigiBase...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Roberta Noseda, Paolo Ripellino, Sara Ghidossi, Raffaela Bertoli, Alessandro Ceschi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2021-09-01
Edice:	Vaccines
Témata:	acute inflammatory neuropathy COVID-19 vaccines VigiBase safety disproportionality
On-line přístup:	https://www.mdpi.com/2076-393X/9/9/1022
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!